These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27580586)

  • 1. Development of a core outcome set for clinical trials in rosacea: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Iyengar S; Williamson PR; Schmitt J; Johannsen L; Maher IA; Sobanko JF; Cartee TV; Schlessinger D; Poon E; Alam M
    Trials; 2016 Sep; 17(1):429. PubMed ID: 27580586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Lazaroff JM; Godinez-Puig V; Chen BR; Kurta AO; Henley JK; Chiren SG; Furlan KC; Schmitt J; Deckert S; Poon E; Sobanko JF; Cartee TV; Alam M; Maher IA
    Trials; 2017 Oct; 18(1):490. PubMed ID: 29061190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Henley JK; Ashchyan HJ; Kurta AO; Patel PM; Sheikh UA; Franklin MJ; Hanna CC; Chen BR; Chiren SG; Schmitt J; Deckert S; Furlan KC; Poon E; Maher IA; Cartee TV; Sobanko JF; Alam M
    Trials; 2017 Aug; 18(1):359. PubMed ID: 28764734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Chiren SG; Godinez-Puig V; Chen BR; Kurta AO; Schmitt J; Deckert S; Furlan KC; Poon E; Cartee TV; Maher IA; Alam M; Sobanko JF
    Trials; 2017 Jul; 18(1):321. PubMed ID: 28701207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement.
    Dirr MA; Ahmed A; Schlessinger DI; Haq M; Shi V; Koza E; Ma M; Christensen RE; Ibrahim SA; Schmitt J; Johannsen L; Asai Y; Baldwin HE; Berardesca E; Berman B; Vieira AC; Chien AL; Cohen DE; Del Rosso JQ; Dosal J; Drake LA; Feldman SR; Fleischer AB; Friedman A; Graber E; Harper JC; Helfrich YR; Jemec GB; Johnson SM; Katta R; Lio P; Maier LE; Martin G; Nagler AR; Neuhaus IM; Palamar M; Parish LC; Rosen T; Shumack SP; Solomon JA; Tanghetti EA; Webster GF; Weinkle A; Weiss JS; Wladis EJ; Maher IA; Sobanko JF; Cartee TV; Cahn BA; Alam M; ; Kang BY; Iyengar S; Anvery N; Alpsoy E; Bewley A; Dessinioti C; Egeberg A; Engin B; Gollnick HPM; Ioannides D; Kim HS; Lazaridou E; Li J; Lim HG; Micali G; de Oliveira CMM; Noguera-Morel L; Parodi A; Reinholz M; Suh DH; Sun Q; van Zuuren EJ; Wollina U; Zhou Y; Zip C; Poon E; Pearlman R
    JAMA Dermatol; 2024 Jun; 160(6):658-666. PubMed ID: 38656294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey.
    MacLennan S; Bekema HJ; Williamson PR; Campbell MK; Stewart F; MacLennan SJ; N'Dow JM; Lam TB
    Trials; 2015 Mar; 16():76. PubMed ID: 25887437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a core outcome set for oral health services research involving dependent older adults (DECADE): a study protocol.
    Watson S; McMullan J; Brocklehurst P; Tsakos G; Watt RG; Wassall RR; Sherriff A; Ramsay SE; Karki AJ; Tada S; Lappin C; Donaldson M; McKenna G
    Trials; 2020 Jul; 21(1):599. PubMed ID: 32611443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis.
    Tallouzi MO; Mathers JM; Moore DJ; Murray PI; Bucknall N; Blazeby JM; Calvert M; Denniston AK
    Trials; 2017 Dec; 18(1):576. PubMed ID: 29191216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Core Outcome Set for Studies on Obesity in Pregnant Patients (COSSOPP): a study protocol.
    Dadouch R; Faheim M; Juando-Prats C; Parsons J; D'Souza R;
    Trials; 2018 Nov; 19(1):655. PubMed ID: 30482249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core Outcome Set for Actinic Keratosis Clinical Trials.
    Reynolds KA; Schlessinger DI; Vasic J; Iyengar S; Qaseem Y; Behshad R; DeHoratius DM; Denes P; Drucker AM; Dzubow LM; Etzkorn JR; Harwood C; Kim JYS; Lee EH; Lissner GS; Marghoob AA; Matin RN; Mattox A; Mittal BB; Thomas JR; Zhou XA; Zloty D; Schmitt J; Kirkham J; Poon E; Sobanko JF; Cartee TV; Maher IA; Alam M
    JAMA Dermatol; 2020 Mar; 156(3):326-333. PubMed ID: 31939999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core outcome research measures in anal cancer (CORMAC): protocol for systematic review, qualitative interviews and Delphi survey to develop a core outcome set in anal cancer.
    Fish R; Sanders C; Williamson PR; Renehan AG
    BMJ Open; 2017 Nov; 7(11):e018726. PubMed ID: 29170292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protocol for developing, disseminating, and implementing a core outcome set for pre-eclampsia.
    Duffy JM; van 't Hooft J; Gale C; Brown M; Grobman W; Fitzpatrick R; Karumanchi SA; Lucas N; Magee L; Mol B; Stark M; Thangaratinam S; Wilson M; von Dadelszen P; Williamson P; Khan KS; Ziebland S; McManus RJ;
    Pregnancy Hypertens; 2016 Oct; 6(4):274-278. PubMed ID: 27939467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
    Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
    BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a core outcome set and outcome measurement set for physiotherapy trials in adults with Bronchiectasis (COS-PHyBE study): A protocol.
    Hamzeh H; Spencer S; Kelly C
    PLoS One; 2022; 17(2):e0263695. PubMed ID: 35134099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twin-Twin Transfusion Syndrome: study protocol for developing, disseminating, and implementing a core outcome set.
    Khalil A; Perry H; Duffy J; Reed K; Baschat A; Deprest J; Hecher K; Lewi L; Lopriore E; Oepkes D;
    Trials; 2017 Jul; 18(1):325. PubMed ID: 28709445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'core outcome set'.
    Prinsen CA; Vohra S; Rose MR; King-Jones S; Ishaque S; Bhaloo Z; Adams D; Terwee CB
    Trials; 2014 Jun; 15():247. PubMed ID: 24962012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for development of a core outcome set for clinical trials in melasma.
    Ibrahim SA; Kang BY; Schlessinger DI; Chiren SG; Tang JC; Kirkham JJ; Schmitt J; Poon E; Maher IA; Sobanko JF; Cartee TV; Alam M
    BMJ Open; 2022 Feb; 12(2):e046953. PubMed ID: 35121595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A core outcome domain set for clinical research on capillary malformations (the COSCAM project): an e-Delphi process and consensus meeting.
    Langbroek GB; Wolkerstorfer A; Horbach SER; Spuls PI; Kelly KM; Robertson SJ; van Raath MI; Al-Niaimi F; Kono T; Boixeda P; Laubach HJ; Badawi AM; Rubin AT; Haedersdal M; Manuskiatti W; van der Horst CMAM; Ubbink DT;
    Br J Dermatol; 2022 Nov; 187(5):730-742. PubMed ID: 35762296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting.
    Lang KM; Harrison KL; Williamson PR; Huntly BJP; Ossenkoppele G; Geissler J; Bereczky T; Hernández-Rivas JM; Chevrou-Séverac H; Goodbody R; Schulze-Rath R; Bullinger L
    Trials; 2020 May; 21(1):437. PubMed ID: 32460828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.